Premium
Evommune Inc (EVMN)
NYSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Eqt Fund Management S.à R.L. | Institution | 4 929 633 | 13,69% | US$ 63,20M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 3 494 638 | 9,70% | US$ 44,80M | 2026-03-31 |
| Pivotal BioVenture Partners LLC | Institution | 3 367 975 | 9,35% | US$ 43,18M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 2 710 293 | 7,52% | US$ 34,75M | 2026-02-17 |
| Andera Partners | Institution | 1 897 362 | 5,27% | US$ 24,32M | 2026-03-31 |
| Pivotal bioVenture Partners Fund I, L.P. | Institution | 1 632 441 | 4,53% | US$ 20,93M | 2025-12-31 |
| RTW Investments, LP | Institution | 1 502 235 | 4,17% | US$ 19,26M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 455 863 | 4,04% | US$ 18,66M | 2026-03-31 |
| JP Morgan Asset Management | Institution | 1 431 761 | 3,98% | US$ 18,36M | 2026-03-31 |
| Symbiosis Capital Partners, LLC | Institution | 1 280 778 | 3,56% | US$ 16,42M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 1 209 129 | 3,36% | US$ 15,50M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1 119 021 | 3,11% | US$ 14,35M | 2026-03-31 |
| B Capital Group Management, L.P. | Institution | 1 104 384 | 3,07% | US$ 14,16M | 2025-11-06 |
| Janus Henderson Group plc | Institution | 896 700 | 2,49% | US$ 11,50M | 2026-03-31 |
| Marshall Wace LLP | Institution | 879 728 | 2,44% | US$ 11,28M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 847 390 | 2,35% | US$ 10,86M | 2026-03-31 |
| RA Capital Nexus Fund III, L.P. | Institution | 784 345 | 2,18% | US$ 10,06M | 2026-02-17 |
| Alyeska Investment Group, L.P. | Institution | 726 362 | 2,02% | US$ 9,31M | 2026-03-31 |
| Defilade Capital Management, L.P. | Institution | 678 589 | 1,88% | US$ 8,70M | 2026-03-31 |
| BlackRock, Inc. | Institution | 673 571 | 1,87% | US$ 8,64M | 2026-03-31 |
| Kynam Capital Management, LP | Institution | 625 496 | 1,74% | US$ 8,02M | 2026-03-31 |
| New Emerging Medical Opportunities Fund V SCSP | Institution | 589 005 | 1,64% | US$ 7,55M | 2025-11-06 |
| Sectoral Asset Management Inc. | Institution | 589 005 | 1,64% | US$ 7,55M | 2026-03-31 |
| Verition Fund Management LLC | Institution | 549 991 | 1,53% | US$ 7,05M | 2026-03-31 |
| Mr. Luis Pena | Initiés | 496 144 | 1,38% | US$ 6,36M | 2026-06-01 |
| American Century Investment Management Inc | Institution | 492 938 | 1,37% | US$ 6,32M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 455 051 | 1,26% | US$ 5,83M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 448 350 | 1,24% | US$ 5,75M | 2026-03-31 |
| Velan Capital Partners LP | Institution | 446 255 | 1,24% | US$ 5,72M | 2026-03-31 |
| Freestone Grove Partners LP | Institution | 337 291 | 0,94% | US$ 4,32M | 2026-03-31 |
| Federated Hermes, Inc. | Institution | 325 000 | 0,90% | US$ 4,17M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 325 000 | 0,90% | US$ 4,17M | 2026-03-31 |
| UBS Asset Management AG | Institution | 298 375 | 0,83% | US$ 3,83M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 248 611 | 0,69% | US$ 3,19M | 2026-03-31 |
| E Fund Management Co., Ltd. | Institution | 243 700 | 0,68% | US$ 3,12M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 225 000 | 0,62% | US$ 2,88M | 2026-03-31 |
| StemPoint Capital LP | Institution | 193 777 | 0,54% | US$ 2,48M | 2026-03-31 |
| Nextbio Capital Management Lp | Institution | 184 063 | 0,51% | US$ 2,36M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 184 062 | 0,51% | US$ 2,36M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 179 511 | 0,50% | US$ 2,30M | 2026-03-31 |
| Monashee Investment Management, LLC | Institution | 179 340 | 0,50% | US$ 2,30M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
